Lack of clinical usefulness of Das-1 monoclonal antibody and mucin expression as risk markers of gastric carcinoma in patients with gastric intestinal metaplasia

American Journal of Clinical Pathology

Volumn 131, Issue 1, 2009, Pages 99-105

  Forné, Montserrat ^a,b   Fernández Bañares, Fernando ^a   González Mínguez, Clarisa ^b   Casalots, Jaume ^b   Poblet Mas, Núria ^c   Garcia Gil, L Jesús ^c   Esteve, Maria ^a   Rosinach, Mercè ^a   Espinós, Jorge ^a   Loras, Carme ^a   Salas, Antonio ^b   Viver, Josep M ^a  

^a Department of Gastroenterology ^*  (Spain)

^b HOSPITAL MÚTUA DE TERRASSA   (Spain)

^c UNIVERSITY OF GIRONA   (Spain)

Author keywords

Das 1; Gastric adenocarcinoma; Gastric intestinal metaplasia; Helicobacter pylori; Monoclonal antibody; Mucins

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY DAS 1; MUCIN; UNCLASSIFIED DRUG;

ARTICLE; ATROPHIC GASTRITIS; CANCER RISK; CHRONIC GASTRITIS; CONTROLLED STUDY; DUODENUM ULCER; GASTRIC INTESTINAL METAPLASIA; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; METAPLASIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CARCINOMA; STOMACH ULCER;

ADULT; AGED; ANTIBODIES; ANTIBODIES, MONOCLONAL; GASTRITIS; HELICOBACTER PYLORI; HUMANS; METAPLASIA; MIDDLE AGED; MUCINS; RISK; STOMACH; STOMACH NEOPLASMS; STOMACH ULCER;

EID: 58549098747     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCPNP7BK3KUUOJL     Document Type: Article

References (24)

1. Morson BC, Sobin LH, Grundmann E, et al. Precancerous conditions and epithelial dysplasia in the stomach. J Clin Pathol. 1980;33:711-721.
2. Correa P. A human model of gastric carcinogenesis. Cancer Res. 1988;48:3554-3560.
3. Shimoyama T, Fukuda S, Tanaka M, et al. Evaluation of the applicability of the gastric carcinoma risk index for intestinal type cancer in Japanese patients infected with Helicobacter pylori. Virchows Arch. 2000;436:585-587.
4. Petersson F, Borch K, Franzen LE. Prevalence of subtypes of intestinal metaplasia in the general population and in patients with autoimmune chronic atrophic gastritis. Scand J Gastroenterol. 2002;37:262-266.
5. Fennerty MB, Emerson JC, Sampliner RE, et al. Gastric intestinal metaplasia in ethnic groups in the southwestern United States. Cancer Epidemiol Biomarkers Prev. 1992;1:293-296.
6. Parkin DM. International variation. Oncogene. 2004;23:6329-6340.
7. You WC, Li JY, Blot WJ, et al. Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer. Int J Cancer. 1999;83:615-619.
8. Smith JL, Dixon MF. Is subtyping of intestinal metaplasia in the upper gastrointestinal tract a worthwhile exercise? an evaluation of current mucin histochemical stains. Br J Biomed Sci. 2003;60:180-186.
9. Mirza ZK, Das KK, Slate J, et al. Gastric intestinal metaplasia as detected by a monoclonal antibody is highly associated with gastric adenocarcinoma. Gut. 2003;52:807-812.
10. Das KM, Sakamaki S, Vecchi M, et al. The production and characterization of monoclonal antibodies to a human colonic antigen associated with ulcerative colitis: cellular localization of the antigen by using the monoclonal antibody. J Immunol. 1987;139:77-84.
11. Kesari KV, Yoshizaki N, Geng X, et al. Externalization of tropomyosin isoform 5 in colon epithelial cells. Clin Exp Immunol. 1999;118:219-227.
12. Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis: the updated Sydney System: International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161-1181.
13. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma: an attempt at histoclinical classification. Acta Pathol Microbiol Scand. 1965;64:31-49.
14. Freeman GH, Halton JH. Note on exact treatment of contingency, goodness of fit and other problems of significance. Biometrika. 1951;38:141-149.
15. Svanholm H, Starklint H, Gundersen HJ, et al. Reproducibility of histomorphologic diagnoses with special reference to the kappa statistic. APMIS. 1989;97:689-698.
16. O'Connell FP, Wang HH, Odze RD. Utility of immunohisto-chemistry in distinguishing primary adenocarcinomas from metastatic breast carcinomas in the gastrointestinal tract. Arch Pathol Lab Med. 2005;129:338-347.
17. Everhart JE, Kruszon-Moran D, Perez-Perez GI, et al. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infect Dis. 2000;181:1359-1363.
18. Garcia-Gonzalez MA, Lanas A, Quintero E, et al. Gastric cancer susceptibility is not linked to pro- and anti-inflammatory cytokine gene polymorphisms in whites: a nationwide multicenter study in Spain. Am J Gastroenterol. 2007;102:1-15.
19. Piazuelo MB, Haque S, Delgado A, et al. Phenotypic differences between esophageal and gastric intestinal metaplasia. Mod Pathol. 2004;17:62-74.
20. El-Zimaity HM, Ramchatesingh J, Saeed MA, et al. Gastric intestinal metaplasia: subtypes and natural history. J Clin Pathol. 2001;54:679-683.
21. Reis CA, David L, Correa P, et al. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res. 1999;59:1003-1007.
22. Silva E, Teixeira A, David L, et al. Mucins as key molecules for the classification of intestinal metaplasia of the stomach. Virchows Arch. 2002;440:311-317.
23. Teixeira A, David L, Reis CA, et al. Expression of mucins (MUC1, MUC2, MUC5AC, and MUC6) and type 1 Lewis antigens in cases with and without Helicobacter pylori colonization in metaplastic glands of the human stomach. J Pathol. 2002;197:37-43.
24. Niwa T, Ikehara Y, Nakanishi H, et al. Mixed gastric- and intestinal-type metaplasia is formed by cells with dual intestinal and gastric differentiation. J Histochem Cytochem. 2005;53:75-85.